share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股sec公告 ·  07/23 16:22
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company, with an aggregate market value of $97,040.46, on 07/23/2024. These shares were originally acquired on 09/01/2016 as founder's shares and were part of Blake's compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $688,144.26.
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company, with an aggregate market value of $97,040.46, on 07/23/2024. These shares were originally acquired on 09/01/2016 as founder's shares and were part of Blake's compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $688,144.26.
Recursion Pharmaceuticals, Inc.董事Borgeson Blake将在2024年07月23日出售公司的11,447股A类股,市值合计为$97,040.46。这些股份最初是作为创始人股份在2016年09月01日获得的,并且是Blake从发行人那里获得的补偿。这次计划的出售是在过去三个月的一系列交易之后,总共出售了77,289股,总收入为$688,144.26。
Recursion Pharmaceuticals, Inc.董事Borgeson Blake将在2024年07月23日出售公司的11,447股A类股,市值合计为$97,040.46。这些股份最初是作为创始人股份在2016年09月01日获得的,并且是Blake从发行人那里获得的补偿。这次计划的出售是在过去三个月的一系列交易之后,总共出售了77,289股,总收入为$688,144.26。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息